MRD Monitoring in Acute Lymphoblastic Leukemia

0 意见
administrator
administrator
06/15/23

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个